– Acquisition of remote training & virtual training app Jolokia, growing revenues and blue chip customer base.

– How new “pandemic paradigm” is helping driving explosive revenue growth

– Update on operations and growth strategy

– PLUS: Will Kanye West be using NEXCF’s AR capture and 3D ad network to sell sneakers?

NexTech will be a featured presenter at Wall Street Reporter’s NEXT SUPER STOCK livestream May 6, 2020.

Click here to join the livestream

attendee.gotowebinar.com/register/175…418620509456

Hosted on Acast. See acast.com/privacy for more information.

Topics discussed:

• Launch of “V-Commerce” initiative which is a potential “game changer” for bricks and mortar retailers as it allows for immersive product experiences – allowing retailers to maximize their revenues and decrease costs. (NEXCF’s technology solution could mean billions in profits and cost savings for retailers.)
• How NexTech is positioned itself at the intersection and transformation of the entire $3.7 trillion dollar (Statista) (TRILLION with a T) retail ecosystem with the industries first state of the art one-stop E-commerce, V-commerce AR/VR solution.
• Some thoughts on institutional investor interest in the AR them, and possible factors driving the stock run up +90% in the past 7 days.

NEXCF stock has increased from $0.52 at the time of the company’s August 15, 2019 debut at the NEXT SUPER STOCK conference to a recent high of $2.38 – an increase of +357%.

Disclaimer: https://www.wallstreetreporter.com/legal-notice/

Hosted on Acast. See acast.com/privacy for more information.

Nightfood Holdings, Inc. (OTC: NGTF) CEO Interview with Sean Folkson, discussing the company’s latest progress in expanding national distribution, and sales of it’s innovative ice cream brand, which serves the $50 billion+ nighttime snacking category.

Topics discusses include:

• Recent Harris Poll survey which indicates over 700 million nighttime snacking occasions each week, and how Nightfood ice cream is a perfect fit for this market opportunity
• National distribution expansion, including hospitality markets, and why hotels are an exciting new opportunity for Nightfood to expand national brand awareness and sales.
• Multi-billion dollar upside opportunity for Nightfood in “owning the night time snacking category”
• Overview of accomplishments for first year of product sales in 2019.
• Growth objectives for 2020, and beyond.

Hosted on Acast. See acast.com/privacy for more information.

Topics discusses include:

• Recent Harris Poll survey which indicates over 800 million nighttime snacking occasions each week, and how Nightfood ice cream is a perfect fit for this market opportunity
• National distribution expansion, including hospitality markets, and why hotels are an exciting new opportunity for Nightfood to expand national brand awareness and sales.
• Multi-billion dollar upside opportunity for Nightfood in “owning the night time snacking category”
• Overview of accomplishments for first year of product sales in 2019.
• Growth objectives for 2020, and beyond.

Hosted on Acast. See acast.com/privacy for more information.

Since our last interview in June, NGTF has made significant progress. In this interview, Sean updates investors on the latest developments for the company’s innovative Nightfood ice cream brand – which targets the $50 billion “late night snacking” market.

Topics discussed, include:

• Latest national distribution expansion, including hospitality market. 
• Product and marketing strategy
• How Nightfood is following the successful playbook of billion dollar ice cream brands
• And more!

Sean will be presenting at Wall Street Reporter’s NEXT SUPER STOCK conference on November 14, 2019. Sign up now, to join the livestream event on November 14, and ask Sean your questions.

Hosted on Acast. See acast.com/privacy for more information.

In this interview, CEO Evan Gappleberg updates investors on NEXCF’s latest growth initiatives since their 8/15 and 9/26 Next Super Stock conference presentations, including record revenue growth, new AR technologies being developed, launching the AR 3D ad network, AR Studio’s “portal” technology for AR entertainment experiences, entry into the AdTech space and more. 

NEXCF stock is up 152% (as of 10/31/19) since first introduced at the Next Super Stock Conference, and in this interview, Evan explains why this could just be the beginning…

Hosted on Acast. See acast.com/privacy for more information.

• NEXCF is the only “pure play” Augmented Reality stock
• NEXCF recently reported gross revenue of $1,632,196 and a gross profit of $787,464 for year ending May 31st 2019. NEXCF is targeting “10X revenue growth for calendar year 2020”
• NEXCF has created the Augmented Reality industry’s first end-to-end affordable, intelligent, frictionless, scalable platform and is now capitalizing on the emerging multi-billion dollar AR market, with a three-ported approach including: AR-driven entertainment, and education technologies, and notably Airtize(tm) for AR-powered e-commerce, which includes major customers like Budweiser.

Hosted on Acast. See acast.com/privacy for more information.

Hoth Therapeutics, Inc. (NASDAQ: HOTH) Interview with CEO Robb Knie, discussing the company’s pipeline of unique targeted dermatological therapies, for indications including: eczema, psoriasis, chronic wound disorders, and acne which address multi-billion dollar market opportunities.

Robb provides an overview of the company’s BioLexa platform, and how it offers a shortened path towards regulatory approval, and the near-term catalysts for value creation. 

Robb, also explains why Hoth is a compelling value proposition for investors based on recent M&A activity in the dermatological space, including the $4.9 billion paid by Pfizer (NYSE: PFE) for Anacor, whose lead product lead product, Eucrisa, is a topical treatment for mild to moderate eczema. 

Hosted on Acast. See acast.com/privacy for more information.

Although was GrowPod’s were initially designed with “mainstream” organic produce farmers and consumers in mind, the economics of this technology are uniquely compelling for cannabis grower. 

As a result, Shannon explains why he expects GP Solutions will soon be selling 100 GrowPod’s monthly (at $80,000-100,000 each) and potentially generating $100 million annual revenues. 

Hosted on Acast. See acast.com/privacy for more information.

Phunware is the only fully-integrated enterprise software platform for mobile. The company's MaaS (Multiscreen as a Service) platform touches over 1 billion mobile devices each month. Alan talks about the company's business model serving Fortune 1000 customers, and how Phunware's use of blockchain will be a game changer for the mobile ad spending and consumer rewards market. 

Alan explains why Phunware is uniquely positioned to "win the new Decentralized Computing era which will be the source of the next $100 billion company".  

Hosted on Acast. See acast.com/privacy for more information.

H.C. Wainwright recently reiterated it’s BUY recommendation with a price target of $1.50 within 12 months.

CytoDyn’s combination therapy for HIV is expected to receive FDA approval in 2019, and potentially generating revenues by early 2020. Especially compelling is the possibility of CytoDyn’s HIV monotherapy which could get potential FDA approval the following year. CytoDyn’s monotherapy is a potential “game changer” in HIV treatment, requiring only a once-weekly injection which can be self-administered. 

Dr. Pourhassan provides an update on CytoDyn’s recent news developments.

Hosted on Acast. See acast.com/privacy for more information.

Randall explains the opportunity for Phuncoin as a consumer rewards eco-system, which brings consumers and brands together, and disintermediates data collectors like Facebook.

Hosted on Acast. See acast.com/privacy for more information.

The only significant barrier in the way, is the approval of an environmental permit from New Zealand authorities. Chris articulates the reasons why the permit was denied in the company’s first attempt, and what new factors are now in place which he believes will assure success this time. 

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

In this follow-up to our December 20, 2018 interview, Penny discusses the company’s progress since the December 2018 IPO, and her vision for positioning and growing the business at the (multi-billion dollar) “intersection of cannabis & wellness”.

Topics discussed include:

• Expanding distribution for Urban Juve’s line of organic cosmetics and wellness products (infused with cannabis sativa hemp root oil) targeting a multi-billon opportunity in the cosmetics and wellness markets.
• Launch of Wright & Well CBD products to 400+ stores in Oregon
• Expansion plans for California market, and international sales
• And more!

Hosted on Acast. See acast.com/privacy for more information.

NGTF has just launched its ice cream brand, and Sean provides an update on the national distribution rollout, positive feedback from retailers, and consumers, including winning “Product of the Year” award.

Sean outlines a goal of being in 10,000 stores by next year which should drive revenues of $30-50 million, and how NGTF is following in the footsteps of other innovative ice cream brands which rapidly became billion dollar brands within a few years. 

Hosted on Acast. See acast.com/privacy for more information.

Cobalt is a key ingredient in electric vehicle, and energy storage batteries. In this interview, Anthony explains how Cobalt27 is structured to offer investors a proxy on the rapidly growing electric vehicle and energy storage markets, via its cobalt mining royalty streams, and physical ownership of cobalt metal (which has current market value of about $200 million).

Topics discussed include:

– Overview of cobalt market

– Update on recent acquisitions

– Possibility of dividend payments, as cashflow from royalties begins in 2019

– Cobalt27’s assets located in politically stable Canada & Australia (Vs. Congo)

– Why stock is intrinsically undervalued today, and offers upside potential

– And more…

Hosted on Acast. See acast.com/privacy for more information.

The company is at a key inflection point, with potential FDA approval for PRO140 for treating HIV expected in 2019. 

Dr. Pourhassan explains the PRO140 technology, its numerous advantages over current HIV therapies on the market, market potential, as well as expanding PRO140’s indications for treating cancer. 

Hosted on Acast. See acast.com/privacy for more information.

The company’s is growing revenues at a rapid pace: For the 9 months, ending 9/30/2018, total income increased to $9,917,476 (compared to total income of $2,585,479 in same period 2017).

Net income increased dramatically to $5,157,717 or $0.19 per share, compared to losses of ($4,868,859) or ($0.22) for the same 9 month period ending September 30, 2017.

Andy, also talks about plans for growth in 2019 and beyond, which include, expanding into marijuana cultivation, and capitalizing on M&A opportunities as the industry consolidates. 

Hosted on Acast. See acast.com/privacy for more information.

Paul also talks about the company’s business strategy, and the plans for deploying a recent AUD$40 million capital raise, to expand global sales growth.

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.